Food. Nutrition. Technologies
Medstrada is a new venture capital fund focusing on food and nutrition technologies.
Our multidisciplinary background in life science, venture capital and food industry replicate the convergence of the health and food industries.
Our vision is Healthy Food, Healthy Living, Healthy Planet.
Learning from the past we have set our mission to improve and change the food chain across all its components, taking into account the implications on Health, wellness and sustainability.
We have been working for decades with entrepreneurs and management teams in pursing the goals of achieving strong brands, using successful strategies for business growth. We have a wide network of exceptionally talented people in both domestic and international markets who can help fulfill your vision.
We are looking for entrepreneurs with exceptional ideas who have set their mind to bring to the global market leading brands and technologies that are disruptive in affecting the health of people and planet.
In the era of food and health convergence and the emergence of FoodTech we pursue investment opportunities in Novel Food, Personalized Nutrition, Food Data and Analytics, and Healthy Planet.
Value-added food with clear benefit.
Healthier, all natural, nutritious products.
New Ingredients // Nutraceuticals // Alternative Proteins // Functional Foods Aqua Food // New Food Production Systems
Understanding human nutrition and creating the right solution for each individual.
Microbiome // Genetics // Dietary Habits // Diagnostic // Tracking Devices // Innovative Sensors
Leveraging Artificial Intelligence ,data-driven analytics platforms to support food industry eco-system.
Artificial Intelligence // Machine Learning // Big Data Analytics // IOT // Blockchain
Purposeful usage of technologies to protect long term planet resources.
Food Safety // Food Security // Biodegradable Packaging // Waste Management // “Green” Chemistry // Circular Economy Business Models
Ruti Alon is a highly experienced investor with over 35 years of experience. Ruti was a General Partner at Pitango Venture Capital, the largest venture capital fund in Israel. In Pitango Ruti founded and led the life science practice.
Ruti is also an investor and a board member of several private and NASDAQ companies. Ruti founded and led as a Chairperson the Israeli Life Science Industries organization and Co-Founded the Israeli Advanced Technologies Industries organization, both been impactful components in establishing the well known Israeli eco-system.
Ruti began her career in Wall Street where she was ranked as top-rated Senior Healthcare Analyst for many years.
Ilanit Kabessa Cohen is a food and consumer industry innovation leader with a proven track record of over 20 years. She founded and led Nestle Israel Innovation and digital business unit for the past 7 years and was a core-team member in Nestle global innovation headquarter. Ilanit has led the innovation strategy, product development and business growth of over 15 international and domestic food superbrands in 35 categories.
Ilanit founded and led Nestle Israel Open Innovation hub, thus establishing Nestle Global Headquarter relationship with Israeli startups.
Ilanit has a background in design and trends forecasting which have been demonstrated both in academia and business domains.
Prof. Zamir Halpern MD serves as the Head of the Gastroenterology Department and Deputy General Manager at Tel Aviv Sourasky Medical center. Prof. Halpern serves as the Head of The Department of Gastroenterology and Liver Diseases at the Sourasky Medical Center (Ichilov Hospital) and a professor of internal medicine at Tel Aviv University, both in Tel Aviv, Israel. He is the Chairman of the National gastro nutrition and liver diseases Council, the Ministry of Health.
He serves as a consultant to various food and healthcare companies. He is one of the leading gastroenterologists in Israel and well recognized over the world. He has vast clinical experience in Israel and abroad, among others at the Department of Gastroenterology and Gastrointestinal Research Unit, Cleveland Clinic Foundation; the Academic Department of Medicine, The Royal Free Hospital, London and Tel Aviv Sourasky Medical Center.
He is the author of more than 150 scientific publications. His main interest is in personal nutrition and GI immunology.
Prof. Amir Lerman MD is a professor of medicine and a consultant in the department of cardiovascular disease at the Mayo graduate school of medicine. Prof. Lerman serves as an associate chair of the department of Cardiology and the medical director of the Mayo-Israeli start up companies initiative.
Prof. Lerman is on the faculty member of the Merage Institute for medical innovation. Prof. Leman interest is in the effect of healthy food on the cardiovascular system including vascular health, regenerative medicine, and the use of digital health.
Prof. Lerman published more than 550 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research.
Prof. Dror Haratz MD, CEO of VBL Therapeutics (NASDQ:VBLT) has over 20 years of both research in the field of medicine and biotechnology as well as a strong background in management of early to mid stage biotechnology companies.
Prof. Harats is also an experienced consultant specializing in Biotechnology / Pharmaceutical / food companies. Dror, is a professor of medicine in the department of internal medicine and the department of human molecular genetics and biochemistry at the Sackler Faculty of Medicine, Tel-Aviv University, is the head of the Bert Strassburger Lipid Center and the chairman of the IRB committee of the Sheba Medical Center.
For the past 25 years Prof. Harats has been involved in “cutting edge” Research in Lipid Metabolism, Atherosclerosis and Vascular Biology. Prof. Harats is a KOL in the field of dyslipidemia and atherosclerosis both in Israel and abroad.
Prof. Harats published more than 165 peer-reviewed research papers and chapters in books, his publications rewarded him with numerous prizes and grants.